Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Teladoc Health in a research note issued on Thursday, February 27th. Cantor Fitzgerald analyst S. James expects that the health services provider will post earnings of ($0.78) per share for the year. The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share.
Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%.
TDOC has been the subject of a number of other reports. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research note on Friday, January 24th. The Goldman Sachs Group dropped their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Bank of America raised their target price on Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research report on Wednesday, February 12th. Eleven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $11.26.
Get Our Latest Stock Analysis on Teladoc Health
Teladoc Health Stock Performance
Shares of TDOC traded up $0.34 during mid-day trading on Monday, reaching $9.37. The company had a trading volume of 13,570,918 shares, compared to its average volume of 8,469,351. The stock has a market capitalization of $1.63 billion, a P/E ratio of -1.62 and a beta of 1.27. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $15.95. The stock has a 50 day moving average of $10.62 and a two-hundred day moving average of $9.62. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TDOC. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider's stock valued at $15,617,000 after buying an additional 228,004 shares during the last quarter. Jennison Associates LLC purchased a new stake in Teladoc Health during the 3rd quarter valued at about $1,544,000. Massachusetts Financial Services Co. MA raised its holdings in Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider's stock valued at $3,397,000 after acquiring an additional 305,961 shares during the last quarter. Geode Capital Management LLC raised its holdings in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock valued at $36,042,000 after acquiring an additional 56,864 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. purchased a new position in Teladoc Health in the 3rd quarter worth approximately $11,291,000. Hedge funds and other institutional investors own 76.82% of the company's stock.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
